AI & Clinical Research
Objectives of the group
To contribute to the attractiveness of France for the realization of Clinical Research (CR) on its territory:
- Map the uses of AI in clinical research for each of our professions, as well as the associated tools
- Accelerate the development and adoption of AI in our businesses
- Ensure the ethics and safety of AI in clinical research
- Represent the interests of clinical research companies in discussions on AI in health
Actions
To do this, we will answer these questions as technological advances and uses occur:
- What solutions exist for a given profession? How effective are these tools?
- What can we increase: productivity, quality, relevance…?
- Is this legal? What are the responsibilities?
- Is it risky, particularly in terms of confidentiality or intellectual property?
- What are the obstacles in practice (internal and external)?
Functioning
Group Members
- Sami Ben Abdallah | BluePharm
- Nesrine Benyahia | DrData
- Véronique Chapalain | ICTA
- Eve Dupas | KYomed INNOV
- David Gibon | AQUILAB
- Margaux Gouysse | Heva
- Flore Jacoud | PELyon
- Delphine Ladarré | Clin’S MD
- Daniel Laune | KYomed INNOV
- Marie Laurent | Heva
- Stéphanie Le Goaller | Biotrial
- Pierre Le Guellec | YEC’ HED MAT
- Sébastien Leuillet | Biofortis (co-animateur du groupe de travail)
- Matthieu Marchand | VCLS
- Flavien Roux | RCTs
- Hervé Servy | Sanoïa (co-animateur du groupe de travail)
- Paskëll Stephan-Sieffert | Euraxi
- Vincent Susplugas | Collective Thinking
Attractiveness
Acting with and with all stakeholders to make France an attractive country for Clinical Research
Medical devices
French expertise on the clinical evaluation of medical devices
Clinical Research Professions
Promote clinical research careers among students and professionals
Real world data
French expertise on real life primary and secondary data
AI & Clinical Research
Use of Artificial Intelligence to serve our CRO professions
Patients and Clinical Research
Patients at the heart of clinical research
Regulatory
single convention
Monitor the use of the single convention
Regulatory
CPP-ANSM
Follow the regulations relating to study authorization requests
Regulatory
CNIL-RGPD
Follow health data protection regulations
Human vigilance
To develop and share good practices for the professional achievement of Clinical Research staff
Decentralised clinical trials
Reflections on the creation of an agile and secure methodology for the development of decentralised clinical trials in France.